Home Stock

Stock Research: Quest Diagnostics

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Quest Diagnostics

NYQ:DGX US74834L1008
83
  • Value
    95
  • Growth
    67
  • Safety
    Safety
    63
  • Combined
    68
  • Sentiment
    85
  • 360° View
    360° View
    83
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Quest Diagnostics Incorporated is a provider of diagnostic information services, offering insights from laboratory testing to improve health outcomes. It operates in the diagnostic information services industry, primarily under the Quest Diagnostics brand, and also includes AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum. The company provides broad access to clinical testing through a nationwide network of laboratories and patient service centers, indicating operations primarily in the United States. In the last fiscal year, the company had 45000 employees, a market capitalization of $18578 million, profits of $3273 million, and revenue of $9872 million.

more
Strongest Rank Leverage
Weakest Rank Pro Holdings
Country USA
Industry Health Care Services
Size X-Large
Website questdiagnostics.com
Index
D.J. US Health Care
S&P 500
Quest Diagnostics stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
95 59 76 83
Growth
67 52 7 37
Safety
Safety
63 11 54 58
Sentiment
85 83 37 89
360° View
360° View
83 45 30 93
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
11 52 28 40
Opinions Change
50 43 25 55
Pro Holdings
n/a 100 55 95
Market Pulse
96 94 71 78
Sentiment
85 83 37 89
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
95 59 76 83
Growth
67 52 7 37
Safety Safety
63 11 54 58
Combined
68 18 35 78
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
89 16 20 34
Price vs. Earnings (P/E)
51 44 61 54
Price vs. Book (P/B)
69 38 50 71
Dividend Yield
100 93 94 92
Value
95 59 76 83
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
46 29 12 5
Profit Growth
60 54 27 66
Capital Growth
76 42 28 33
Stock Returns
35 75 23 71
Growth
67 52 7 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
5 36 46 52
Refinancing
10 19 27 37
Liquidity
100 26 71 71
Safety Safety
63 11 54 58

Similar Stocks

Discover high‑ranked alternatives to Quest Diagnostics and broaden your portfolio horizons.

Micron

NSQ:MU
Country: USA
Industry: Semiconductors
Size: XX-Large
Full Stock Analysis

Salesforce

NYQ:CRM
Country: USA
Industry: Application Software
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NSQ:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Walt Disney

NYQ:DIS
Country: USA
Industry: Movies & Entertainment
Size: XX-Large
Full Stock Analysis

Frequently Asked
Questions

This is a high-quality, high-growth stock with positive sentiment. However, the financing is on the riskier side. It is best for a growth-focused investor willing to accept higher financial risk for potentially higher shareholder returns.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews